Literature DB >> 12654567

Treatment strategies for hepatocellular carcinoma in cirrhosis.

W Scott Helton1, Adrian Di Bisceglie, Ravi Chari, Myron Schwartz, Jordi Bruix.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12654567     DOI： 10.1016/s1091-255x(02)00161-0

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  79 in total

1.  Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials.

Authors:  J M Llovet; J Bustamante; A Castells; R Vilana; M del C Ayuso; M Sala; C Brú; J Rodés; J Bruix
Journal:  Hepatology       Date:  1999-01       Impact factor: 17.425

2.  Influence of associated viral hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy.

Authors:  S Ko; Y Nakajima; H Kanehiro; T Kin; Y Aomatsu; A Yoshimura; J Taki; K Yagura; K Ohashi; H Nakano
Journal:  World J Surg       Date:  1996-10       Impact factor: 3.352

3.  The long term efficacy of glycyrrhizin in chronic hepatitis C patients.

Authors:  Y Arase; K Ikeda; N Murashima; K Chayama; A Tsubota; I Koida; Y Suzuki; S Saitoh; M Kobayashi; H Kumada
Journal:  Cancer       Date:  1997-04-15       Impact factor: 6.860

4.  Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus.

Authors:  B J McMahon; P Holck; L Bulkow; M Snowball
Journal:  Ann Intern Med       Date:  2001-11-06       Impact factor: 25.391

5.  Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis.

Authors:  S A Curley; F Izzo; L M Ellis; J Nicolas Vauthey; P Vallone
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

6.  Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation.

Authors:  J M Llovet; X Mas; J J Aponte; J Fuster; M Navasa; E Christensen; J Rodés; J Bruix
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

7.  Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Authors:  J M Llovet; C Brú; J Bruix
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

8.  Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.

Authors:  J Bruix; A Castells; J Bosch; F Feu; J Fuster; J C Garcia-Pagan; J Visa; C Bru; J Rodés
Journal:  Gastroenterology       Date:  1996-10       Impact factor: 22.682

Review 9.  Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation.

Authors:  E Mor; R Tur-Kaspa; P Sheiner; M Schwartz
Journal:  Ann Intern Med       Date:  1998-10-15       Impact factor: 25.391

10.  Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients.

Authors:  A Castells; J Bruix; C Brú; C Ayuso; M Roca; L Boix; R Vilana; J Rodés
Journal:  Gastroenterology       Date:  1995-09       Impact factor: 22.682
View more
  8 in total

1.  Disparities in care for patients with curable hepatocellular carcinoma.

Authors:  Blaire Burman; W Scott Helton
Journal:  HPB (Oxford)       Date:  2015-09       Impact factor: 3.647

2.  Future perspectives for hepatocellular carcinoma.

Authors:  W Y Lau
Journal:  HPB (Oxford)       Date:  2003       Impact factor: 3.647

Review 3.  Current opinion on the role of resection and liver transplantation for hepatocellular cancer.

Authors:  P Puneet; M T P R Perera; Darius F Mirza
Journal:  Indian J Gastroenterol       Date:  2012-06-19

4.  Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma.

Authors:  Patrick P McHugh; Jeffrey Gilbert; Santiago Vera; Alvaro Koch; Dinesh Ranjan; Roberto Gedaly
Journal:  HPB (Oxford)       Date:  2010-02       Impact factor: 3.647

5.  Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients: a multivariate analysis.

Authors:  Marco Montorsi; Roberto Santambrogio; Paolo Bianchi; Matteo Donadon; Eliana Moroni; Antonino Spinelli; Mara Costa
Journal:  J Gastrointest Surg       Date:  2005-01       Impact factor: 3.452

Review 6.  Current management strategy of hepatocellular carcinoma.

Authors:  Bernardino Rampone; Beniamino Schiavone; Antonio Martino; Carmine Viviano; Giuseppe Confuorto
Journal:  World J Gastroenterol       Date:  2009-07-14       Impact factor: 5.742

7.  Real-time spectroscopic assessment of thermal damage: implications for radiofrequency ablation.

Authors:  Christopher D Anderson; Wei-Chiang Lin; Clay R Buttemere; M Kay Washington; Anita Mahadevan-Jansen; Janene Pierce; Ian B Nicoud; C Wright Pinson; Ravi S Chari
Journal:  J Gastrointest Surg       Date:  2004 Sep-Oct       Impact factor: 3.267

8.  Chronic viral hepatitis and hepatocellular carcinoma.

Authors:  Yagil Barazani; Jonathan R Hiatt; Myron J Tong; Ronald W Busuttil
Journal:  World J Surg       Date:  2007-06       Impact factor: 3.282
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.